Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 14
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Alaunos Therapeutics Inc
TCRT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$3.03
1.98
188.57%
Ult. Agg.: Oct 13, 8:00 PM
$3.89
2.84
270.48%
Get Report
Panoramica
Notizie
Previsioni utili
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
PRO
Perché si muove?:
Alaunos Therapeutics shares are trading higher after the company announced ...
Alaunos Therapeutics Financials
Alaunos Therapeutics (TCRT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Alaunos Therapeutics Q2 EPS $(0.63) Up From $(0.71) YoY
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 percent increase over losses of $(0.71) per share from the same period last year.
Benzinga Newsdesk
Recap: Alaunos Therapeutics Q3 Earnings
Benzinga Insights
PRO
Alaunos Therapeutics Q3 EPS $(0.04), Same As Last Year
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share. This is unchanged from the same period last year.
Benzinga Newsdesk
PRO
Alaunos Therapeutics Q2 EPS $(0.04), Inline
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.
Benzinga Newsdesk
Earnings Scheduled For May 10, 2023
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
Benzinga Insights
PRO
Alaunos Therapeutics Q1 EPS $(0.04), Inline
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.
Benzinga Newsdesk
